William F. Pierce

2.5k citations
26 papers · 1.1k indexed · 1 hit paper · h-index 15

William F. Pierce

23 papers receiving 1.1k citations

Hit Papers

FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxet...202220262023202420224080120

Peers

William F. Pierce
Comparison fields: 5 of 96
  • Oncology 594
  • Pulmonary and Respiratory Medicine 393
  • Radiology, Nuclear Medicine and Imaging 315
  • Molecular Biology 204
  • Cancer Research 162
Replace Tatsu Shimoyama with:
Tatsu Shimoyama Japan
E. Claire Dees United States
J.F. Lester United Kingdom
Ka-On Lam Hong Kong
Aymen Elfiky United States
Richard Turkington United Kingdom
Caio Rocha‐Lima United States
Morena Fasano Italy
Nicola Battelli Italy
Emily Dunn United States
William F. Pierce relative to Tatsu Shimoyama Japan Tatsu Shimoyama's profile →
Citations per field
00.5×2.6×
Tatsu Shimoyama · 1×
Citations per year

Countries citing papers authored by William F. Pierce

Since Specialization
Citations

This map shows the geographic impact of William F. Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William F. Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William F. Pierce more than expected).

Fields of papers citing papers by William F. Pierce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William F. Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William F. Pierce. The network helps show where William F. Pierce may publish in the future.

Co-authorship network of co-authors of William F. Pierce

This figure shows the co-authorship network connecting the top 25 collaborators of William F. Pierce. A scholar is included among the top collaborators of William F. Pierce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William F. Pierce. William F. Pierce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 1
4 2
5 0
6 14
7 9
8 3
9 34
10
FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancerbreakdown →
127
11 56
12 118
13 16
14 8
15 88
16 75
17 1
18 77
19 34
20
The Career Education Concept.
1

About William F. Pierce

William F. Pierce is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Emergency Medical Services, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Advanced Breast Cancer Therapies (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Oncology (594 citations), Radiology, Nuclear Medicine and Imaging (315 citations) and Pulmonary and Respiratory Medicine (393 citations). William F. Pierce has collaborated with scholars based in United States and Japan. Frequent co-authors include Richard Pazdur, Shenghui Tang, Paul G. Kluetz, Kirsten B. Goldberg, Laleh Amiri‐Kordestani, Amna Ibrahim, Marc R. Theoret, Julia A. Beaver, Rajeshwari Sridhara and Todd R. Palmby. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and European Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026